A crossover study to evaluate the efficacy and safety of preprandial human insulin inhalation powder (HIIP) compared to once-daily NPH [insulin suspension isophane] in insulin-naive patients with type 2 diabetes mellitus on oral agents
Latest Information Update: 07 Oct 2014
At a glance
- Drugs Insulin (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 08 Jul 2007 Status changed from initiated
- 25 Jun 2007 New trial record.